Cecile Valette

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In view of the shortcomings of the current system for postmarketing drug surveillance that is based on voluntary spontaneous adverse drug reaction (ADR) reporting, new approaches are needed. We describe an approach involving a combination of limited distribution, patient and physician education, as well as a novel pharmaco-vigilance system that is capable(More)
  • 1